quantisnow
FeedTopReportsPricing
⌘K
Live feed
06:33:18·57d
SECFiling
Recursion Pharmaceuticals Inc. logo

SEC Form 10-K filed by Recursion Pharmaceuticals Inc.

RXRX· Recursion Pharmaceuticals Inc.
Health Care
Full content unavailable. See the original source below.
Original source

Companies

  • RXRX
    Recursion Pharmaceuticals Inc.
    Health Care

Recent analyst ratings

  • Dec 17UpdateAnalyst$11.00
  • Jul 3UpdateMorgan Stanley$5.00
  • May 22UpdateMorgan Stanley$8.00
  • Mar 16UpdateNeedham$17.00
  • Sep 16UpdateKeyBanc Capital Markets$20.00
  • Apr 18UpdateBofA Securities$10.00

Related

  • INSIDER15d
    SEC Form 4 filed by Taylor Ben R
  • INSIDER15d
    SEC Form 4 filed by Gibson Christopher
  • INSIDER15d
    SEC Form 4 filed by Borgeson Blake
  • PR16d
    Recursion to Participate in Upcoming Investor Conferences
  • INSIDER21d
    SEC Form 4 filed by Dar Zavain
  • INSIDER21d
    SEC Form 4 filed by Li Dean Y
  • PR23d
    Recursion Expands Strategic Partnership with Citeline to Advance Its AI-Enabled ClinTech Platform
  • SEC27d
    Amendment: SEC Form SCHEDULE 13G/A filed by Recursion Pharmaceuticals Inc.
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022